Encompass Health Co. (NYSE:EHC) Shares Purchased by American Century Companies Inc.

American Century Companies Inc. raised its position in Encompass Health Co. (NYSE:EHC) by 8.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 468,560 shares of the company’s stock after buying an additional 36,130 shares during the period. American Century Companies Inc. owned about 0.47% of Encompass Health worth $40,198,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Commonwealth Equity Services LLC boosted its stake in shares of Encompass Health by 1.3% in the second quarter. Commonwealth Equity Services LLC now owns 9,845 shares of the company’s stock worth $845,000 after acquiring an additional 123 shares during the last quarter. Legacy Wealth Asset Management LLC lifted its holdings in Encompass Health by 1.5% in the 1st quarter. Legacy Wealth Asset Management LLC now owns 8,619 shares of the company’s stock valued at $712,000 after purchasing an additional 130 shares in the last quarter. Smith Group Asset Management LLC boosted its stake in Encompass Health by 1.2% during the 1st quarter. Smith Group Asset Management LLC now owns 12,070 shares of the company’s stock worth $997,000 after purchasing an additional 140 shares during the last quarter. Horrell Capital Management Inc. grew its holdings in shares of Encompass Health by 0.5% during the first quarter. Horrell Capital Management Inc. now owns 29,371 shares of the company’s stock worth $2,425,000 after buying an additional 147 shares in the last quarter. Finally, GAMMA Investing LLC raised its position in shares of Encompass Health by 31.9% in the first quarter. GAMMA Investing LLC now owns 616 shares of the company’s stock valued at $51,000 after buying an additional 149 shares during the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Encompass Health

In other Encompass Health news, CFO Douglas E. Coltharp sold 12,260 shares of the firm’s stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $86.34, for a total value of $1,058,528.40. Following the completion of the transaction, the chief financial officer now owns 136,227 shares of the company’s stock, valued at approximately $11,761,839.18. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.10% of the company’s stock.

Wall Street Analyst Weigh In

EHC has been the subject of several research reports. Stephens reaffirmed an “overweight” rating and set a $105.00 price objective on shares of Encompass Health in a research note on Tuesday, August 6th. Leerink Partners began coverage on Encompass Health in a report on Wednesday, July 10th. They issued an “outperform” rating and a $100.00 price target for the company. Barclays lowered their price objective on Encompass Health from $113.00 to $109.00 and set an “overweight” rating on the stock in a research note on Tuesday, August 6th. Leerink Partnrs raised Encompass Health to a “strong-buy” rating in a research note on Wednesday, July 10th. Finally, Royal Bank of Canada boosted their price target on shares of Encompass Health from $83.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, May 22nd. Nine investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, Encompass Health has an average rating of “Buy” and a consensus price target of $100.38.

Encompass Health Stock Performance

Shares of EHC stock opened at $91.31 on Wednesday. The company has a debt-to-equity ratio of 1.08, a quick ratio of 1.35 and a current ratio of 1.35. The firm has a market cap of $9.19 billion, a P/E ratio of 24.68, a P/E/G ratio of 1.39 and a beta of 0.88. The firm’s 50 day moving average price is $89.64 and its 200-day moving average price is $85.02. Encompass Health Co. has a one year low of $57.55 and a one year high of $94.59.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Monday, August 5th. The company reported $1.11 EPS for the quarter, topping the consensus estimate of $1.01 by $0.10. The business had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.30 billion. Encompass Health had a return on equity of 17.83% and a net margin of 7.88%. The company’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period last year, the business posted $0.95 earnings per share. As a group, equities research analysts predict that Encompass Health Co. will post 4.18 EPS for the current year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st will be paid a $0.17 dividend. This is a positive change from Encompass Health’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Tuesday, October 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.74%. Encompass Health’s dividend payout ratio (DPR) is presently 18.38%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.